U.S. market Closed. Opens in 46 minutes

ROIVW | Roivant Sciences Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-31
Revenue124.80M61.28M55.29M23.80M67.69M2.32M
Cost of Revenue15.56M13.13M8.97M2.06M1.13M606.00K
Gross Profit109.23M48.15M46.32M21.74M66.56M1.72M
Operating Expenses1.19B1.13B1.26B496.50M598.98M750.21M
Selling, General & Admin687.44M600.51M775.03M259.88M335.77M237.21M
Research & Development501.74M525.22M483.04M236.63M263.22M512.99M
Other Operating Expenses-85.03M-62.19M-81.00K-33.41MN/AN/A
Operating Income4.24B-1.08B-1.21B-1.07B-532.42M-748.49M
Other Expenses / Income5.22B-147.26M288.00M172.35M-28.56M-58.69M
Before Tax Income4.25B-1.22B-923.75M-898.55M-560.99M-807.18M
Income Tax Expenses22.22M5.19M369.00K1.69M7.12M2.62M
Net Income4.35B-1.23B-924.12M-900.23M1.20B-1.04B
Interest Expenses34.78M27.97M7.04M2.81M7.68M7.54M
Basic Shares Outstanding783.25M712.79M669.75M222.67M215.35M215.35M
Diluted Shares Outstanding831.05M712.79M669.75M222.67M215.35M215.35M
EBITDA-996.51M-1.11B-1.50B-510.50M83.85M138.13M
EBITDA Margin-798.52%-1,807.41%-2,712.86%-2,145.42%123.88%5,943.46%
EBIT4.41B-1.20B-916.71M-895.74M1.22B-1.03B
EBIT Margin3,530.53%-1,953.11%-1,658.12%-3,764.40%1,795.44%-44,397.98%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙